These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21146216)

  • 1. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
    Liu Y; Wang Z; Jiang M; Dai L; Zhang W; Wu D; Ruan C
    Leuk Res; 2011 Jul; 35(7):879-84. PubMed ID: 21146216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemia.
    Zhang XH; Hu Y; Bao L; Jiang Q; Yang LH; Lu XJ; Hong M; Xia LH; Guo T; Shen GX; Zhu HH; Zhao T; Song SJ
    Chin Med J (Engl); 2009 Sep; 122(17):1969-73. PubMed ID: 19781379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator.
    Zhang X; Zhou H; Wang J; Yang L; Hu Y; Shen G; Guo P; Qiao Z; Song S
    Thromb Res; 2002 Apr; 106(1):63-70. PubMed ID: 12165291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin II and bleeding in acute promyelocytic leukemia.
    Menell JS; Cesarman GM; Jacovina AT; McLaughlin MA; Lev EA; Hajjar KA
    N Engl J Med; 1999 Apr; 340(13):994-1004. PubMed ID: 10099141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid-induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia.
    Olwill SA; McGlynn H; Gilmore WS; Alexander HD
    Br J Haematol; 2005 Oct; 131(2):258-64. PubMed ID: 16197459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia].
    Liu YH; Wang ZY; Zhang W; Dai L; Shen WH; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):145-9. PubMed ID: 19642359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin II cell surface and mRNA expression in human acute myeloid leukaemia cell lines.
    Olwill SA; McGlynn H; Gilmore WS; Alexander HD
    Thromb Res; 2005; 115(1-2):109-14. PubMed ID: 15567461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The fibrinolytic activity in leukemic cell lines and its alteration on all-trans retinoic acid treatment].
    Xie Y; Wang ZY; Zhang W; Dai L; Bai X
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):588-92. PubMed ID: 17278423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid.
    Wang G; Li W; Cui J; Gao S; Yao C; Jiang Z; Song Y; Yuan CJ; Yang Y; Liu Z; Cai L
    Hematol Oncol; 2004 Jun; 22(2):63-71. PubMed ID: 15468344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.
    Wang P; Zhang Y; Yang H; Hou W; Jin B; Hou J; Li H; Zhao H; Zhou J
    Hematology; 2018 Dec; 23(10):756-764. PubMed ID: 29724147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.
    Raffoux E; Rousselot P; Poupon J; Daniel MT; Cassinat B; Delarue R; Taksin AL; Réa D; Buzyn A; Tibi A; Lebbé G; Cimerman P; Chomienne C; Fermand JP; de Thé H; Degos L; Hermine O; Dombret H
    J Clin Oncol; 2003 Jun; 21(12):2326-34. PubMed ID: 12805334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of arsenic in acute promyelocytic leukemia.
    Tallman MS
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin enhances the antifibrinolytic and antileukemic effects of all-trans retinoic acid in acute promyelocytic leukemia cells.
    Ikezoe T; Yang J; Nishioka C; Isaka M; Iwabu N; Sakai M; Taniguchi A; Honda G; Yokoyama A
    Exp Hematol; 2012 Jun; 40(6):457-65. PubMed ID: 22327096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol-induced up-regulation of candidate plasminogen receptor annexin II in cultured human endothelial cells.
    Tabengwa EM; Abou-Agag LH; Benza RL; Torres JA; Aikens ML; Booyse FM
    Alcohol Clin Exp Res; 2000 Jun; 24(6):754-61. PubMed ID: 10888061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coagulopathy of acute promyelocytic leukaemia revisited.
    Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
    Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.